Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase I Study of Methoxyamine Combined With Chemo-Radiation for Locally Advanced Non-Squamous Non-Small Cell Lung Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02535325
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:36.214292+00:00
Published At
2022-06-30T00:00:00+00:00
Record Updated At
2022-06-30
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma", "Stage III Lung Adenocarcinoma AJCC v7", "Stage III Lung Large Cell Carcinoma AJCC v7", "Stage III Lung Non-Small Cell Cancer AJCC v7", "Stage IIIA Lung Adenocarcinoma AJCC v7", "Stage IIIA Lung Large Cell Carcinoma AJCC v7", "Stage IIIA Lung Non-Small Cell Cancer AJCC v7", "Stage IIIB Lung Adenocarcinoma AJCC v7", "Stage IIIB Lung Large Cell Carcinoma AJCC v7", "Stage IIIB Lung Non-Small Cell Cancer AJCC v7", "Stage IV Lung Adenocarcinoma AJCC v7", "Stage IV Lung Large Cell Carcinoma AJCC v7", "Stage IV Lung Non-Small Cell Cancer AJCC v7"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2022-06-30"
protocolSection.identificationModule.nctId
"NCT02535325"
protocolSection.identificationModule.officialTitle
"A Phase I Study of Methoxyamine Combined With Chemo-Radiation for Locally Advanced Non-Squamous Non-Small Cell Lung Cancer"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage III Lung Adenocarcinoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage III Lung Large Cell Carcinoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage III Lung Non-Small Cell Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIIA Lung Adenocarcinoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIIA Lung Large Cell Carcinoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIIA Lung Non-Small Cell Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIIB Lung Adenocarcinoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIIB Lung Large Cell Carcinoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIIB Lung Non-Small Cell Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IV Lung Adenocarcinoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IV Lung Large Cell Carcinoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IV Lung Non-Small Cell Cancer AJCC v7 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.